
Interpace Biosciences IDXG
€ 1.51
-2.22%
Quartalsbericht 2026-Q1
hinzugefügt 12.05.2026
Interpace Biosciences P/S 2011-2026 | IDXG
P/S Jährlich Interpace Biosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.19 | 0.0879 | 0.149 | 0.821 | 2.72 | 0.5 | 1.19 | 1.16 | 1.09 | 0.577 | 0.443 | 0.194 | 0.574 | 0.885 | 0.609 | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 2.72 | 0.0879 | 0.746 |
P/S anderer Aktien in der Diagnostik & Forschung
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Co-Diagnostics
CODX
|
9.4 | $ 1.29 | -21.17 % | $ 1.72 M | ||
|
Centogene N.V.
CNTG
|
1.72 | - | -6.23 % | $ 30.6 M | ||
|
Fulgent Genetics
FLGT
|
1.65 | $ 15.7 | -3.03 % | $ 475 M | ||
|
Agilent Technologies
A
|
6.64 | $ 111.7 | -1.38 % | $ 34 B | ||
|
Castle Biosciences
CSTL
|
1.37 | $ 19.13 | 1.32 % | $ 555 M | ||
|
Akumin
AKU
|
0.1 | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
5.55 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
13.5 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
0.229 | - | -13.05 % | $ 7.29 M | ||
|
Illumina
ILMN
|
3.75 | $ 142.54 | -0.49 % | $ 22.7 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
5.71 | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
2.61 | $ 19.97 | -2.54 % | $ 1.06 B | ||
|
Chembio Diagnostics
CEMI
|
0.254 | - | 0.22 % | $ 16.8 M | ||
|
Lantheus Holdings
LNTH
|
3.32 | $ 93.91 | -2.86 % | $ 6.34 B | ||
|
HTG Molecular Diagnostics
HTGM
|
0.469 | - | -20.0 % | $ 1.06 M | ||
|
Mettler-Toledo International
MTD
|
7.06 | $ 1 031.64 | -0.99 % | $ 21.3 B | ||
|
Myriad Genetics
MYGN
|
0.496 | $ 3.58 | -1.1 % | $ 332 M | ||
|
Medpace Holdings
MEDP
|
5.12 | $ 415.27 | -0.93 % | $ 12 B | ||
|
Global Cord Blood Corporation
CO
|
0.196 | - | - | $ 399 M | ||
|
NeoGenomics
NEO
|
2.04 | $ 8.24 | -1.44 % | $ 1.06 B | ||
|
Fluidigm Corporation
FLDM
|
3.48 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
1.36 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
2.9 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
2.77 | - | -11.32 % | $ 2.94 M | ||
|
National Research Corporation
NRC
|
2.29 | $ 18.62 | -1.64 % | $ 417 M | ||
|
Charles River Laboratories International
CRL
|
1.92 | $ 150.85 | -5.2 % | $ 7.48 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
2.47 | - | - | $ 10.7 B | ||
|
Natera
NTRA
|
6.47 | $ 186.36 | -5.36 % | $ 18.3 B | ||
|
Enzo Biochem
ENZ
|
0.0018 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
6 | - | - | $ 19.8 B | ||
|
Koninklijke Philips N.V.
PHG
|
1.7 | $ 25.23 | -1.06 % | $ 23.9 B | ||
|
Senseonics Holdings
SENS
|
9.94 | $ 5.77 | -0.86 % | $ 241 M | ||
|
Guardant Health
GH
|
13.7 | $ 94.92 | -3.79 % | $ 11.9 B | ||
|
Personalis
PSNL
|
6.19 | $ 6.36 | -5.22 % | $ 568 M | ||
|
Heska Corporation
HSKA
|
3.28 | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
3.25 | $ 116.38 | -0.61 % | $ 9.6 B | ||
|
Soleno Therapeutics
SLNO
|
10.9 | $ 53.01 | 0.04 % | $ 2.69 B | ||
|
QIAGEN N.V.
QGEN
|
5.03 | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
1.35 | $ 2.34 | -2.9 % | $ 5.38 M | ||
|
Laboratory Corporation of America Holdings
LH
|
1.71 | $ 250.4 | -1.43 % | $ 20.8 B | ||
|
Thermo Fisher Scientific
TMO
|
4.4 | $ 438.34 | -2.2 % | $ 165 B | ||
|
Trinity Biotech plc
TRIB
|
3.15 | $ 0.57 | -1.59 % | $ 205 M | ||
|
Motus GI Holdings
MOTS
|
3.1 | - | -34.28 % | $ 263 K | ||
|
Twist Bioscience Corporation
TWST
|
4.15 | $ 49.17 | -7.14 % | $ 2.94 B | ||
|
Waters Corporation
WAT
|
21.1 | $ 329.22 | -1.2 % | $ 19.6 B | ||
|
Neogen Corporation
NEOG
|
1.14 | $ 8.19 | -2.85 % | $ 1.78 B | ||
|
Quest Diagnostics Incorporated
DGX
|
2.11 | $ 186.61 | -0.71 % | $ 20.7 B |